This case report highlights the risk for vascular abnormalities, including cerebrovascular disease, in MYH11 pathogenic variants and underscores the importance of vigilant monitoring and early prophylactic interventions for stroke prevention in this patient population. This evidence concerns the gene MYH11 and Stroke.